Literature DB >> 33458309

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy.

Tobias Finazzi1, John R van Sörnsen de Koste1, Miguel A Palacios1, Femke O B Spoelstra1, Berend J Slotman1, Cornelis J A Haasbeek1, Suresh Senan1.   

Abstract

BACKGROUND AND
PURPOSE: Single-fraction stereotactic ablative radiotherapy (SABR) is an effective treatment for early-stage lung cancer, but concerns remain about the accurate delivery of SABR in a single session. We evaluated the delivery of single-fraction lung SABR using magnetic resonance (MR)-guidance.
MATERIALS AND METHODS: An MR-simulation was performed in 17 patients, seven of whom were found to be unsuitable, largely due to unreliable tracking of small tumors. Ten patients underwent single-fraction SABR to 34 Gy on a 0.35 T MR-linac system, with online plan adaptation. Gated breath-hold SABR was delivered using a planning target volume (PTV) margin of 5 mm, and a 3 mm gating window. Continuous MR-tracking of the gross tumor volume (GTVt) was performed in sagittal plane, with visual patient feedback provided using an in-room monitor. The real-time MR images were analyzed to determine precision and efficiency of gated delivery.
RESULTS: All but one patient completed treatment in a single session. The median total in-room procedure was 120 min, with a median SABR delivery session of 39 min. Review of 7.4 h of cine-MR imaging revealed a mean GTVt coverage by the PTV during beam-on of 99.6%. Breath-hold patterns were variable, resulting in a mean duty cycle efficiency of 51%, but GTVt coverage was not influenced due to real-time MR-guidance. On-table adaptation improved PTV coverage, but had limited impact on GTV doses.
CONCLUSIONS: Single-fraction gated SABR of lung tumors can be performed with high precision using MR-guidance. However, improvements are needed to ensure MR-tracking of small tumors, and to reduce treatment times.
© 2020 The Authors.

Entities:  

Keywords:  Adaptive radiotherapy; Lung cancer; MR-guided radiation therapy; SABR; Single-fraction

Year:  2020        PMID: 33458309      PMCID: PMC7807654          DOI: 10.1016/j.phro.2020.05.002

Source DB:  PubMed          Journal:  Phys Imaging Radiat Oncol        ISSN: 2405-6316


  42 in total

1.  Frameless high dose rate stereotactic lung radiotherapy: intrafraction tumor position and delivery time.

Authors:  Nicolas Peguret; Max Dahele; Johan P Cuijpers; Ben J Slotman; Wilko F A R Verbakel
Journal:  Radiother Oncol       Date:  2013-05-23       Impact factor: 6.280

2.  Single Fraction SBRT for Early Stage Lung Cancer-Less is More?

Authors:  Shankar Siva; David L Ball
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-03-13       Impact factor: 7.038

Review 3.  MRI-guided lung SBRT: Present and future developments.

Authors:  Martin J Menten; Andreas Wetscherek; Martin F Fast
Journal:  Phys Med       Date:  2017-02-24       Impact factor: 2.685

4.  Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR.

Authors:  Davide Cusumano; Jennifer Dhont; Luca Boldrini; Giuditta Chiloiro; Stefania Teodoli; Mariangela Massaccesi; Bruno Fionda; Francesco Cellini; Luigi Azario; Jef Vandemeulebroucke; Marco De Spirito; Vincenzo Valentini; Dirk Verellen
Journal:  Radiother Oncol       Date:  2018-08-22       Impact factor: 6.280

5.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P E Postmus; K M Kerr; M Oudkerk; S Senan; D A Waller; J Vansteenkiste; C Escriu; S Peters
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

6.  Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience.

Authors:  Houda Bahig; Marie-Pierre Campeau; Toni Vu; Robert Doucet; Dominic Béliveau Nadeau; Bernard Fortin; David Roberge; Louise Lambert; Jean-François Carrier; Edith Filion
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-14       Impact factor: 7.038

7.  Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.

Authors:  S Siva; K Kirby; H Caine; D Pham; T Kron; L Te Marvelde; D Whalley; M J Stevens; F Foroudi; M MacManus; D Ball; T Eade
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-02-16       Impact factor: 4.126

8.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

9.  A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).

Authors:  Gregory M M Videtic; Chen Hu; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Steven E Schild; Ritsuko Komaki; James J Urbanic; Robert D Timmerman; Hak Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-17       Impact factor: 7.038

10.  Markerless positional verification using template matching and triangulation of kV images acquired during irradiation for lung tumors treated in breath-hold.

Authors:  Colien Hazelaar; Max Dahele; Hassan Mostafavi; Lineke van der Weide; Ben Slotman; Wilko Verbakel
Journal:  Phys Med Biol       Date:  2018-05-29       Impact factor: 3.609

View more
  16 in total

1.  MR SIGnature MAtching (MRSIGMA) with retrospective self-evaluation for real-time volumetric motion imaging.

Authors:  Nathanael Kim; Kathryn R Tringale; Christopher Crane; Neelam Tyagi; Ricardo Otazo
Journal:  Phys Med Biol       Date:  2021-10-26       Impact factor: 4.174

Review 2.  Integrated MRI-guided radiotherapy - opportunities and challenges.

Authors:  Paul J Keall; Caterina Brighi; Carri Glide-Hurst; Gary Liney; Paul Z Y Liu; Suzanne Lydiard; Chiara Paganelli; Trang Pham; Shanshan Shan; Alison C Tree; Uulke A van der Heide; David E J Waddington; Brendan Whelan
Journal:  Nat Rev Clin Oncol       Date:  2022-04-19       Impact factor: 65.011

Review 3.  MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology.

Authors:  Ricardo Otazo; Philippe Lambin; Jean-Philippe Pignol; Mark E Ladd; Heinz-Peter Schlemmer; Michael Baumann; Hedvig Hricak
Journal:  Radiology       Date:  2020-12-22       Impact factor: 11.105

Review 4.  MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?

Authors:  Juliane Hörner-Rieber; Sebastian Klüter; Jürgen Debus; Gosse Adema; Marleen Ansems; Marcel Verheij
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

5.  Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.

Authors:  Sebastian Regnery; Carolin Buchele; Fabian Weykamp; Moritz Pohl; Philipp Hoegen; Tanja Eichkorn; Thomas Held; Jonas Ristau; Carolin Rippke; Laila König; Michael Thomas; Hauke Winter; Sebastian Adeberg; Jürgen Debus; Sebastian Klüter; Juliane Hörner-Rieber
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

Review 6.  Patient positioning and immobilization procedures for hybrid MR-Linac systems.

Authors:  Francesco Cuccia; Filippo Alongi; Claus Belka; Luca Boldrini; Juliane Hörner-Rieber; Helen McNair; Michele Rigo; Maartje Schoenmakers; Maximilian Niyazi; Judith Slagter; Claudio Votta; Stefanie Corradini
Journal:  Radiat Oncol       Date:  2021-09-20       Impact factor: 3.481

7.  MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients.

Authors:  Chukwuka Eze; Elia Lombardo; Lukas Nierer; Yuqing Xiong; Maximilian Niyazi; Claus Belka; Farkhad Manapov; Stefanie Corradini
Journal:  Radiat Oncol       Date:  2022-02-24       Impact factor: 3.481

8.  In Silico Single-Fraction Stereotactic Ablative Radiation Therapy for the Treatment of Thoracic and Abdominal Oligometastatic Disease With Online Adaptive Magnetic Resonance Guidance.

Authors:  Sangjune Lee; Poonam Yadav; Albert J van der Kogel; John Bayouth; Michael F Bassetti
Journal:  Adv Radiat Oncol       Date:  2021-01-20

9.  Delivery of online adaptive magnetic resonance guided radiotherapy based on isodose boundaries.

Authors:  Claudio Votta; Davide Cusumano; Luca Boldrini; Nicola Dinapoli; Lorenzo Placidi; Gabriele Turco; Marco Valerio Antonelli; Veronica Pollutri; Angela Romano; Luca Indovina; Vincenzo Valentini
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-07

10.  Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy.

Authors:  Marcel Nachbar; David Mönnich; Oliver Dohm; Melissa Friedlein; Daniel Zips; Daniela Thorwarth
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.